MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. - Wikidata - wikimedia - TriplyDB

MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.

MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.

http://www.wikidata.org/entity/Q34314932

about

Regulation of Bim in Health and Disease MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer The microRNA-183 cluster: the family that plays together stays together MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.MYC regulates the non-coding transcriptome.Taming of the beast: shaping Myc-dependent amplification c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells.Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib The consensus molecular subtypes of colorectal cancer Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.MiR-17 Downregulation by High Glucose Stabilizes Thioredoxin-Interacting Protein and Removes Thioredoxin Inhibition on ASK1 Leading to Apoptosis.Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma MicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinoma Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway.Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia.Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer.A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.MiRNA-based therapeutic intervention of cancer.The role of microRNAs in the pathogenesis of HIV-related lymphomas.MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.MYC regulates the antitumor immune response through CD47 and PD-L1 Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.miR-20a regulates expression of the iron exporter ferroportin in lung cancer.c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.Noncoding RNAs in Cancer Cell Plasticity.Resetting cancer stem cell regulatory nodes upon MYC inhibition.MYC-Master Regulator of the Cancer Epigenome and Transcriptome.The Expression Pattern of MicroRNAs and the Associated Pathways Involved in the Development of Porcine Placental Folds That Contribute to the Expansion of the Exchange Surface Area.MicroRNA inhibition fine-tunes and provides robustness to the restriction point switch of the cell cycle.A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis.Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells.MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.OncomiR-17-5p: alarm signal in cancer?

P2860

Q26781203-40F49D8E-351A-417A-B15D-A1B1C096EFBC Q26785379-B3B1DD9C-C024-49BF-839C-F0B0EB085D0D Q26797469-2FD2AE74-8C01-41F1-B67A-707DD67AB58A Q26801108-BF605862-12FB-4B87-8BEB-80AEE83E6DAE Q28080473-3D6E97D1-E5E8-44E3-B094-566086E5215B Q33829355-7B283673-07EB-43B0-A6D7-F5B8514912CD Q35149681-4C6805DB-F949-4C1F-90FD-DE28A92AF630 Q35235723-E019F665-6BA3-4699-90CB-5C0B1BECFB12 Q35666432-12FCC8FD-6F66-450D-A474-98901A2D04D8 Q35825993-2349FC74-AE97-4C84-88F6-26F0F39F1354 Q36091288-B8BBBE8A-7768-4114-89E1-BE87998479D6 Q36258187-01A2FB64-23BF-41D2-9E4C-D1099664B069 Q36291392-AC9E183F-3DA4-4A61-B32B-C380A9D8D9F1 Q36293209-9BAF0008-7E45-4CD0-8042-70D8854601D9 Q36325517-C72B7757-F30B-4676-A5C4-0278A090BC97 Q36794190-E903B6F4-CBBF-4A65-82D0-4B881BFEA757 Q37100081-E1C9B4F2-5013-4C99-ADE9-89F71226C815 Q37143955-D0860B0E-C229-4536-9119-E84326178D8F Q37206095-41623F16-B575-4938-BE1C-82BEAC958530 Q37269199-481E4ED1-72D0-4693-8E6D-0118848FD8FC Q37317126-7E7F65A0-BA3E-475C-9F71-F2DD1162F6A8 Q37564446-D1D4ECF3-3C8B-4E2E-AB3C-C9CE1F43A80D Q37672145-0A1AB251-F02A-4C15-A802-EBDC28EC36AB Q38524274-0EC92BD2-866C-4E1E-88B3-436C08F768F8 Q38555990-FE84DAB5-2E35-4399-A7A0-73BFD68D6977 Q38739927-7AA1AAA1-E907-456F-B9EE-F8684805E214 Q38780780-F0634B4B-55D3-482E-A3AC-4332EAE812A3 Q38787131-53078ED1-0828-48C6-94A5-8F0D868832B5 Q38799990-4D5F7120-1444-4215-8888-1D4B7587B9EE Q38820031-D5BC1809-0DEC-42EF-B69B-BC7E68F572D5 Q38829331-8B26E368-248B-451B-A675-4EB84E444278 Q38885475-E9EF4285-CC07-4CDA-AB77-A875DAEADE51 Q39182602-3418C6FB-4722-4B03-A819-85A6A697338E Q39306981-0FA664CA-9842-4537-A6AB-39A308A13A60 Q40756070-E381CBB5-75EA-4552-A1DE-E6784CC9DC62 Q41053612-DB3E536D-F6B0-43A9-B981-1B7D131D72E5 Q41082774-7259A3F8-6868-4FA2-84BF-03D2FFAB644E Q41190385-3A64B940-94A7-49B3-BBA1-B2AF26D0585C Q41856692-6597C65F-5E68-4F75-92F9-461E092832F7 Q42378524-59A23184-E408-4698-92FA-A4EDC217C868

P2860

MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.

http://www.wikidata.org/entity/Q34314932

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@ast

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@en

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@nl

type

label

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@ast

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@en

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@nl

prefLabel

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@ast

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@en

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@nl

P1433

Q34314932-18790CB9-2E6E-4FF2-99F2-94AC7FADAE1A

P1476

Q34314932-0AF15EF2-A85B-4A8C-B673-FCEA7F9F450E

P2093

Q34314932-0B39A2A5-F047-416B-8F56-FCD51389F5F9

Q34314932-A7B2CFA9-F18B-4451-B891-2341E301069F

Q34314932-E0FDD7D2-2D37-445F-ACF0-9E0259AAA6EB

Q34314932-F56C611A-86B6-48B2-ADF4-51248EC44A74

P2860

Q34314932-0046DBD4-32FF-46A1-8448-A4FC0BB9DC28

Q34314932-0883F7CD-A7B0-4FE9-8404-2AF17F09252F

Q34314932-1364D7C1-2512-4D8B-8590-FF910133C905

Q34314932-147C5CE0-7623-4540-9FEB-D04AFFA59F07

Q34314932-16C18A2E-A71E-4970-A402-FFC8618DEE09

Q34314932-1B35CE70-DA80-4EFC-836B-5E8351508663

Q34314932-205E02F2-BED4-4BF0-AECE-602A27E2F5A6

Q34314932-25E45CED-6AA6-46C7-BAEB-C0FD20602C56

Q34314932-28FCB919-F06F-453D-BA37-D7E9E1E32B1E

Q34314932-3314AB89-675E-4F83-8FCC-0880C6EA56AE

P304

Q34314932-F427B141-F1A5-48E1-BC99-C5B081B13DEF

P31

Q34314932-B3F09FBC-BD41-4D1E-BD91-9B42B2E0982F

P356

Q34314932-74D73368-F4D6-43A4-BF21-0AB28ACAF3F0

P433

Q34314932-0586AC3B-C23E-4AE8-A53D-E7D1979A3A53

P478

Q34314932-6ED12E20-607C-4467-8FFE-2FEC85AB219B

P50

Q34314932-8784BF98-DCCD-445B-9320-457DDFDF3696

P577

Q34314932-497D0A6E-F22C-4F94-9BA7-3D9783C2951F

P698

Q34314932-01BC2ADD-31E6-4B85-BC42-CB609A498ADC

P932

Q34314932-C795A930-3CB4-4221-9A50-63BE99048D6D

P356

J.CCR.2014.06.014

P1433

P1476

MYC through miR-17-92 suppress ...... ation, and a neoplastic state.

@en

P2093

Dean W Felsher

http://www.w3.org/2001/XMLSchema#string

Peter S Choi

http://www.w3.org/2001/XMLSchema#string

Stephanie C Casey

http://www.w3.org/2001/XMLSchema#string

Yulin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

Global mapping of c-Myc binding sites and target gene networks in human B cells

The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure

P304

262-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2014.06.014

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25117713

http://www.w3.org/2001/XMLSchema#string

P932

4191901

http://www.w3.org/2001/XMLSchema#string